Hospital General Universitario De Castellon — Clinical Trial Site

49 Registered trials

19 Currently recruiting

Organisation

Hospital General Universitario De Castellon

Location

Castello De La Plana, Spain

Identifier

ORG-100042135

Address

Avenida De Benicasim S/n, 12004, Spain

Departments

#40839: Reumatología
#40839:Servicio de Reumatología
#7015:Reumatología
Alergología
Alergology
Allergollogy
Allergology
Cardiology
Cirugía
Hematología
Intensive Care Unit
Multidisciplinary Unit of Abdominopelvic Oncologic Surgery
Nefrology
Nephrology
Neurology
Neurophysiology
Neurophysiology Dept.
Oncology
Peris
Pneumology
Reumathology
Reumatología
Rheumatology
Servicio de Oncología
Sleep unit
Urologia
Urology

Clinical trials at this site (49)

Search interface

In vivo biological standardization of Dermatophagoides allergen extracts. Not authorised

2024-514108-15-00 Allergies 4
A clinical trial to evaluate the efficacy and safety of a mixture of allergenic extracts of D. pteronyssinus and D. farinae, in patients suf… Pending

2025-521230-29-00 Allergic rhinoconjunctivitis to Dermatophagoides pteron 5
Prospective, randomized, multicentre study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the pr… Pending

2025-521301-40-00 Prevention of new morphometric vertebral fractures and/ 6
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (P… Pending

2025-522471-28-00 psoriatic arthritis (PsA) 5
A Study of Enpatoran in Cutaneous Manifestations of Lupus With or Without Systemic Disease. Pending

2025-524855-30-00 Cutaneous Manifestations of Lupus Erythematosus With or 5
Grass/Olive Immunotherapy for Rhinitis and Asthma (GOES) Recruiting

2025-521709-42-00 Allergic rhinoconjunctivitis with or without asthma due 5 2026-06-23
Grass Immunotherapy for Rhinitis and Asthma (GIRA) Recruiting

2025-521736-10-00 Allergic rhinoconjunctivitis with or without controlled 5 2026-06-23
Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 10 2023-07-17
Efficacy of the use of neoadjuvant with/without hyperthermic intraperitoneal chemotherapy in the treatment of locally advanced colon cancer Recruiting

2025-520471-29-00 Locally advanced adenocarcinoma of the colon and upper 5 2026-05-26
A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting

2025-522979-29-00 Acute myeloid leukemia 5 2026-04-30
Trial of Trastuzumab Deruxtecan in Combination with Pembrolizumab Versus Pembrolizumab with Platinum-based Chemotherapy in First-line HER2 o… Recruiting

2024-515658-26-00 Unresectable or Metastatic HER2 overexpressing and PD-L 5 2026-01-21
A Phase 3, Randomized, Open-label, Multicenter Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System … Recruiting

2024-519493-39-00 High-risk Non-muscle-invasive Bladder Cancer with Susce 5 2025-12-09
Dose determination study of a mix of Dermatophagoides allergenic extracts (pteronyssinus and farinae) for immunotherapy treatment, administe… Recruiting

2025-521522-15-00 Allergic rhinitis/rhinoconjunctivitis caused by dust mi 4 2025-11-05
Non-Invasive Ventilation versus High Flow Oxygenotherapy in Patients at High Risk of Extubation Failure Recruiting

2024-514640-81-00 Weaning of Mechanical ventilation 6 2025-04-23
A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo and risankizumab (active reference arm) in partici… Recruiting

2024-516219-25-00 psoriatic arthritis 5 2025-03-25
A study describing the efficacy and safety of belimumab administered subcutaneously in adult participants with early systemic lupus erythema… Recruiting

2023-509146-35-00 Systemic Lupus Erythematosus 6 2025-01-30
COLCHICINE IN SECONDARY PREVENTION OF VASCULAR EVENTS AND RENAL PROGRESSION IN PATIENTS WITH MODERATE CHRONIC RENAL DISEASE Recruiting

2023-505868-11-00 CHRONIC RENAL DISEASE 5 2025-01-17
A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting

2023-508191-11-00 Systemic lupus erythematosus (SLE) 5 2024-11-28
A study comparing TAR-210 versus single agent treatment instilled directly into the bladder in people with bladder cancer with FGFR gene alt… Recruiting

2023-507684-19-00 FGFR+ Intermediate-risk Non-muscle Invasive Bladder Can 5 2024-07-24
Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism Recruiting

2024-511959-18-01 Acute Pulmonary Embolism 5 2024-07-01
Phase II study of axitinib intensification plus standard of care (SOC) compared to SOC alone after induction with nivolumab plus ipilimumab … Recruiting

2024-511397-70-00 metastatic renal cell carcinoma (mRCC) 4 2024-05-06
Prospective randomised study of the impact of preoperative administration of mitomycin-C by electromotive drug administration (EMDA) in pat… Recruiting

2024-510867-42-00 non-muscle invasive bladder tumors 6 2023-04-24
Multicentre Phase IV clinical trial to evaluate the efficacy of hyperthermic intraoperative chemotherapy (HIPEC) with Mitomycin-C after comp… Recruiting

2024-512726-28-00 peritoneal metastases of colorectal cancer 6 2022-02-14
EVALUATION OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS IMMUNOTHERAPY (BELTAVAC®) WITH POLYMERIZED ALLERGENIC EXTRACT OF HOUSE DUST MITE MIXTU… Recruiting

2024-516893-31-01 Allergic rhinoconjunctivitis due to exposure of house d 5 2022-01-31